- Corporate Officers - C
- Conterno Enrique A
Insider Trading History of Conterno Enrique A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Conterno Enrique A since 2012.
This trader's CIK number is 1476151.
At the time of last reporting, Conterno Enrique A was the Chief Executive Officer of Fibrogen Inc. (stock ticker symbol FGEN).
Also see all insider trading activities at Fibrogen Inc.
Note that in the past
Conterno Enrique A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Fibrogen Inc (FGEN) by Conterno Enrique A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | FGEN | 0 | $0 | 68,907 | $1,353,287 | 0 | $0 |
| 2022 | FGEN | 0 | $0 | 2,543 | $40,153 | 0 | $0 |
| 2020 | FGEN | 27,800 | $988,883 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Eli Lilly & Co (LLY) by Conterno Enrique A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | LLY | 0 | $0 | 25,000 | $3,025,000 | 12,222 | $0 |
| 2018 | LLY | 0 | $0 | 25,000 | $2,125,000 | 41,326 | $0 |
| 2017 | LLY | 0 | $0 | 25,000 | $2,069,000 | 10,244 | $0 |
| 2016 | LLY | 0 | $0 | 0 | $0 | 10,360 | $0 |
| 2015 | LLY | 0 | $0 | 25,000 | $2,097,000 | 20,918 | $389,215 |
| 2014 | LLY | 0 | $0 | 25,000 | $1,610,350 | 22,775 | $395,170 |
| 2013 | LLY | 0 | $0 | 25,000 | $1,354,600 | 41,768 | $0 |
| 2012 | LLY | 0 | $0 | 20,000 | $845,399 | 0 | $0 |
Insider trading activities at 2 companies by Conterno Enrique A:
1. Fibrogen Inc (FGEN)
2. Eli Lilly & Co (LLY)
Table 1. Insider trading of Fibrogen Inc (FGEN) by Conterno Enrique A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-07-07 | FGEN | Sale | 1,880 | 2.80 | 5,264 |
| 2023-06-07 | FGEN | Sale | 8,897 | 17.04 | 151,578 |
| 2023-04-10 | FGEN | Sale | 1,869 | 19.52 | 36,482 |
| 2023-03-08 | FGEN | Sale | 24,672 | 21.16 | 521,960 |
| 2023-03-10 | FGEN | Sale | 31,589 | 20.20 | 638,003 |
| 2022-12-08 | FGEN | Sale | 2,543 | 15.79 | 40,153 |
| 2020-06-10 | FGEN | Buy | 8,000 | 36.28 | 290,280 |
| 2020-06-11 | FGEN | Buy | 19,800 | 35.28 | 698,603 |
Table 2. Insider trading of Eli Lilly & Co (LLY) by Conterno Enrique A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-02-15 | LLY | Sale | 25,000 | 121.00 | 3,025,000 |
| 2019-02-01 | LLY | Option Ex | 12,222 | .00 | 0 |
| 2018-05-31 | LLY | Sale | 25,000 | 85.00 | 2,125,000 |
| 2018-05-01 | LLY | Option Ex | 20,000 | .00 | 0 |
| 2018-02-01 | LLY | Option Ex | 21,326 | .00 | 0 |
| 2017-05-04 | LLY | Sale | 25,000 | 82.76 | 2,069,000 |
| 2017-02-01 | LLY | Option Ex | 10,244 | .00 | 0 |
| 2016-02-01 | LLY | Option Ex | 10,360 | .00 | 0 |
| 2015-12-09 | LLY | Sale | 25,000 | 83.88 | 2,097,000 |
| 2015-11-12 | LLY | Option Ex | 6,928 | 56.18 | 389,215 |
| 2015-02-01 | LLY | Option Ex | 13,990 | .00 | 0 |
| 2014-12-10 | LLY | Option Ex | 7,101 | 55.65 | 395,170 |
| 2014-11-03 | LLY | Sale | 5,000 | 66.03 | 330,150 |
| 2014-10-01 | LLY | Sale | 5,000 | 64.86 | 324,300 |
| 2014-09-02 | LLY | Sale | 5,000 | 63.60 | 318,000 |
| 2014-07-25 | LLY | Sale | 10,000 | 63.79 | 637,900 |
| 2014-02-01 | LLY | Option Ex | 15,674 | .00 | 0 |
| 2013-08-15 | LLY | Sale | 5,000 | 53.79 | 268,950 |
| 2013-07-15 | LLY | Sale | 5,000 | 51.43 | 257,150 |
| 2013-06-17 | LLY | Sale | 5,000 | 52.45 | 262,250 |
| 2013-05-15 | LLY | Sale | 5,000 | 56.15 | 280,750 |
| 2013-05-01 | LLY | Option Ex | 10,000 | .00 | 0 |
| 2013-04-15 | LLY | Sale | 5,000 | 57.10 | 285,500 |
| 2013-02-01 | LLY | Option Ex | 31,768 | .00 | 0 |
| 2012-08-01 | LLY | Sale | 5,000 | 44.16 | 220,799 |
| 2012-07-02 | LLY | Sale | 5,000 | 43.00 | 215,000 |
| 2012-06-01 | LLY | Sale | 5,000 | 40.60 | 203,000 |
| 2012-05-01 | LLY | Sale | 5,000 | 41.32 | 206,600 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Conterno Enrique A
(Chief Executive Officer of Fibrogen Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.